Peng Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 15
- Oncology 52
- Cancer Immunotherapy and Biomarkers 19
- Co-authors
- Bjoern PetersAlessandro SetteJohn SidneyBianca R. MothéCourtney DowLin ZhangJian YuYo-Han Kim
- Journals
- Nature Communications (5 papers)PLoS ONE (4 papers)Oncotarget (4 papers)Cell Death and Disease (4 papers)Cancer Research (3 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Peng Wang
197 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Cancer Research 1.2k
- Immunology 1.1k
- Molecular Biology 3.5k
- Oncology 1.0k
- Epidemiology 1.1k
Countries citing papers authored by Peng Wang
This map shows the geographic impact of Peng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Wang more than expected).
Fields of papers citing papers by Peng Wang
This network shows the impact of papers produced by Peng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Wang. The network helps show where Peng Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 16 | |
| 14 | 2019 | 265 | |
| 15 | 2018 | 65 | |
| 16 | 2017 | 34 | |
| 17 | MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1. | 2015 | 39 |
| 18 | 2014 | 17 | |
| 19 | 2011 | 129 | |
| 20 | 2005 | 11 |
About Peng Wang
Peng Wang is a scholar working on Cancer Research, Oncology, Aging, Epidemiology and Molecular Biology, having authored 219 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), Autophagy in Disease and Therapy (25 papers), RNA Research and Splicing (20 papers), Cancer Immunotherapy and Biomarkers (19 papers), MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Immunology (1.1k citations), Molecular Biology (3.5k citations), Oncology (1.0k citations) and Epidemiology (1.1k citations). Peng Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Bjoern Peters, Alessandro Sette, John Sidney, Bianca R. Mothé, Courtney Dow, Lin Zhang, Jian Yu, Yo-Han Kim, Ole Lund and Morten Nielsen. Their work appears in journals such as Nature Communications, PLoS ONE, Oncotarget, Cell Death and Disease and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.